Research Paper

D-Allulose Regulates Obesity via Endoplasmic Reticulum Stress-Mediated Glucagon-Like Peptide-1 Receptor Pathway

A New Molecular Mechanism Behind Allulose and Obesity A 12 week study in Antioxidants & Redox Signaling traced how allulose regulates obesity down to a specific cellular pathway. T

Published 2025-07-01

Antioxidants & Redox Signaling

Lee GH; Lee HY; Lim YJ; Kim JH; Rah SY; Chung MJ; Park SY; Sa S; Lee H; Soh Y; Kim J; Chae HJ

A New Molecular Mechanism Behind Allulose and Obesity

A 12-week study in Antioxidants & Redox Signaling traced how allulose regulates obesity down to a specific cellular pathway. The finding: allulose stabilizes the GLP-1 receptor by dampening endoplasmic reticulum (ER) stress — and when the receptor is knocked out, allulose's effects disappear.

That knockout result is the key. It turns a correlation into a mechanism: allulose's anti-obesity effects run through the GLP-1 receptor.

Why GLP-1 Receptor Signaling Matters

GLP-1 receptor signaling sits at the center of modern obesity treatment. The most effective weight-loss drugs on the market — semaglutide, tirzepatide — work through GLP-1 pathways.

The question for a food ingredient is whether it can support that pathway naturally, at dietary doses. This study suggests allulose can, through a defined molecular route.

The Mechanism, Step by Step

The study mapped a precise cascade:

  1. ER stress and ROS. In obesity, endoplasmic reticulum stress and reactive oxygen species rise, disrupting cellular function.
  2. The NADP+/NADPH ratio. This redox balance signal activates IRE1α, a major ER-stress sensor.
  3. RIDD. Activated IRE1α triggers RIDD (regulated IRE1-dependent decay), which degrades specific mRNAs — including, newly shown here, the GLP-1 receptor mRNA.
  4. The outcome. GLP-1 receptor levels fall, weakening GLP-1 signaling.

D-allulose inhibits this axis. It keeps the GLP-1 receptor from decaying, preserving its function.

What the Experiments Showed

In Vitro: Adipocyte Differentiation

Allulose regulated adipocyte differentiation by inhibiting the NADP+/NADPH-ROS-IRE1α-RIDD axis, controlling decay of GLP-1R — a newly identified RIDD target. In plain terms, allulose helps keep a healthy pool of functional GLP-1 receptors.

In Vivo: High-Fat Diet Mice

Over 12 weeks on a high-fat diet, allulose administration significantly regulated body weight and other obesity markers compared with high-fat controls.

The Knockout Proof

In GLP-1R knockout mice, allulose's anti-obesity effects did not appear. That is strong evidence the benefits depend on GLP-1R — not on some unrelated metabolic effect.

What It Means

Insight Implication
Mechanism identified Allulose stabilizes GLP-1R via the ER-stress pathway
Causality proven GLP-1R knockout abolishes the effect
Obesity link Allulose regulates body weight in high-fat-diet mice
Beyond sweetness Allulose is metabolically active, not inert

For Formulators and Brands

This is another peer-reviewed brick in the wall separating allulose from "just another sweetener." It strengthens the scientific case for allulose in products positioned around weight and metabolic health.

The realistic framing: allulose supports metabolic health by helping the body's own GLP-1 system work. It is a dietary tool, not a weight-loss drug — modest, dietary-level support is the honest claim.

Frequently Asked Questions

Q: Does allulose cause weight loss? Animal studies show allulose regulates body weight in high-fat-diet models. Human data shows modest metabolic support, but allulose is a dietary tool, not a weight-loss drug.

Q: How does this relate to Ozempic/Wegovy? Both engage the GLP-1 system, but through different mechanisms and magnitudes. Allulose nudges your own GLP-1 signaling at mealtime; those drugs flood the system with synthetic analogs.

Q: Is the effect proven in humans? The mechanism is established in animal models. Human trials on allulose and GLP-1 support the general direction, but this specific ER-stress mechanism still needs human confirmation.

Wrap-Up

This study identifies a concrete molecular mechanism — allulose stabilizing the GLP-1 receptor through ER-stress regulation — and proves causality with knockout experiments. It strengthens allulose's case as a functional, metabolically active sweetener for weight and metabolic health applications.

Read the full paper: Antioxidants & Redox Signaling | DOI: 10.1089/ars.2025.0158

Research Source

DOI: 10.1089/ars.2025.0158

View original paper

Need Allulose Application Guidance?

Our technical team can help evaluate allulose for sugar reduction, texture, browning, and label-planning projects.